DSHEA Strategy: “Signal Detection” Is First Defense To Detect Adverse Events
This article was originally published in The Tan Sheet
Executive Summary
FDA will employ a "signal detection" process for evaluating and monitoring safety issues related to supplements on the market
You may also be interested in...
FDA Budget Reaffirms Commitment To OTCs, Reduces Supplement Programs
FDA hopes to increase the number of over-the-counter drugs on the market as part of its long-term goal to provide consumers with safe, effective and affordable drugs, the agency states in its fiscal year 2007 budget request presentation
FDA Budget Reaffirms Commitment To OTCs, Reduces Supplement Programs
FDA hopes to increase the number of over-the-counter drugs on the market as part of its long-term goal to provide consumers with safe, effective and affordable drugs, the agency states in its fiscal year 2007 budget request presentation
FDA Budget Reaffirms Commitment To OTCs, Reduces Supplement Programs
FDA hopes to increase the number of over-the-counter drugs on the market as part of its long-term goal to provide consumers with safe, effective and affordable drugs, the agency states in its fiscal year 2007 budget request presentation